
    
      All patients who present with Covid-19-like symptoms within 5 days prior to consult, who
      consent to participate in the study, will undergo a nasopharyngeal swab (NP) collected for
      SARS-CoV-2 RT-PCR with EUA as per standard of care and nasal swab collection for CoviDx Rapid
      Antigen testing.
    
  